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Case Report

A rare case of three years disease free survival in a locally advanced
parathyroid carcinoma successfully excised by complete surgical resection
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Parathyroid carcinoma (PC) is one of the rarest malignancies making approximately 0.005% of all cancers. It
may arise sporadically or less commonly, in conjunction with genetic endocrine syndromes. Due to the rarity of
the disease, no general consensus or deﬁnitive guidelines exist for its pre-operative diagnosis, management, or
follow up. Surgical tumor removal is the gold standard treatment to prevent its recurrence. Parathyroid carcinoma has a high recurrence rate ranging from 40 to 60% in recent literature. We report a case of a seventy-yearold elderly female with locally advanced parathyroid carcinoma successfully surgically excised completely with
a 3 year disease free survival period without adjuvant chemotherapy or radiotherapy.

1. Introduction
Parathyroid carcinoma (PC) is one of the rarest malignancies
making approximately 0.005% of all cancers [1,2]. Recent literature
suggests that it accounts for only 0.5–5% of all the cases of primary
hyperparathyroidism, with less than 1000 cases reported in the literature since it was ﬁrst discovered in 1904 [3–5]. It may arise sporadically or less commonly, in conjunction with genetic endocrine syndromes such as multiple endocrine neoplasia (MEN) type 1, type 2A,
and hyperparathyroidism jaw-tumor syndrome (HPT-JT) [6–8]. Diagnosis is usually diﬃcult and challenging due to the absence of clinical
and radiological characteristics that reliably distinguish benign from
malignant disease [1,2,6]. Due to the rarity of the disease, no general
consensus or deﬁnitive guidelines exist for its diagnosis, management,
or follow up [6,8,9].
According to recent literature, 90% of parathyroid carcinoma cases
are hormonally functional on presentation with clinically apparent
symptoms of hypercalcemia and severe primary hyperparathyroidism
which include anxiety, depression, loss of appetite, and weight loss
usually present with the renal and skeletal disease [4,6,10]. Serum
calcium is often elevated with greater than 14mg/dl and serum parathyroid hormone is often raised to about three to ten times the upper
limit of normal [1]. Surgery is the mainstay of treatment with complete

resection of the tumor to achieve microscopically negative margins to
prevent recurrence [1,2,6,7,11].
We report a case of an elderly female who presented to us with
initial suspicion of parathyroid adenoma. However, post-operatively
she was diagnosed with parathyroid carcinoma on histopathological
examination.
2. Case report
This is a case of 70 years old female, with no known co-morbidities,
who presented to the Otolaryngology clinic with complaints of increased somnolence and reduced appetite for past the 3–4 years. These
complaints were not associated with any other associated symptoms.
Her past medical history and family history were unremarkable. She
had a history of the cesarean section under spinal anesthesia 30 years
ago. On examination, she was well oriented to time, place, and person.
She had a heart rate of 64 beats per min, a respiratory rate of 16 breaths
per min, a blood pressure of 110/70 mm Hg, and she was afebrile. Her
general physical and systemic examination was also unremarkable. Her
serum calcium was 14.1mg/dl (8.8–10.6) and serum parathyroid hormone showed a value of 457mg/dl (7-53). Her vitamin D level, serum
albumin, and creatinine were all within a normal range. 24-hour urinary calcium and phosphorus were also within normal limits. She
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normal. No other signs of hypocalcemia were noted and serum calcium
was within a normal range. The patient remained stable and hence was
discharged as post-op day 2 on oral calcium supplements and analgesia.
At 1-week follow-up her serum calcium was 8.9mg/dl and serum
parathyroid hormone was 16.3pg/ml. Histopathology revealed a neoplastic lesion composed of closely space clusters of medium-sized ovoid
to polygonal cells with pale to mildly eosinophilic cytoplasm, distinct
cell borders, and centrally placed round to ovoid nuclei showing prominent nucleoli. Moderate cytological atypia and nuclear pleomorphism were seen. Occasional mitotic ﬁgures were consistent with
parathyroid carcinoma. The tumor was seen invading into the thyroid
parenchyma 0.4cm away from the resection/capsular margin
(Fig. 3).Her repeat serum calcium was also within the normal range.
MEN syndrome workup was done which was negative. The patient was
seen regularly for 1 year and then has been on regular follow up yearly
for past three years. She has been doing well with no symptoms and
signs for recurrence of disease. Hence she has an overall disease free
survival of three years with only complete surgical resection of tumor
and no chemotherapy or radiotherapy.
3. Discussion
Parathyroid carcinoma (PC) is one of the rarest endocrine malignancies with an incidence of 0.015 per 100,000 population in the
United States [1,12]. These tumors are hormonally functional with less
than 38 cases reported in the literature for non-functional parathyroid
carcinoma [6]. Hence patients often present with signs and symptoms
of hypercalcemia hyperparathyroidism [6]. Multiple case series suggest
the involvement of renal and skeletal disease in up to 50% of patients in
parathyroid carcinoma with an incidence of nephrolithiasis and renal
insuﬃciency as high as 56 and 84% respectively [13]. Recent studies
also suggest the presence of a palpable cervical mass in about 30–76%
of patients while the incidence of completely asymptomatic parathyroid
carcinoma described in 7–46% of patients and approximately 25% of
patients develop distant metastases at some point during the disease
[6,18]. In contrast, our patient had a hormonally functioning parathyroid carcinoma but she did not develop renal or skeletal disease
despite advanced age and did not have a palpable neck mass.
The pre-operative diagnosis of parathyroid carcinoma is diﬃcult
and challenging due to the absence of diagnostic criteria and a lack of
consensus in literature [8,9]. It should be suspected in a patient with a
very high serum calcium level of greater than 14mg/dl or an increased
parathyroid hormone of greater than three to ten times of upper limit of
normal palpable cervical lymph nodes should also raise suspicion of PC
[9,14]. Neck ultrasonography and parathyroid scintigraphy have been
described as the imaging of choice for detecting parathyroid lesions and
a combination of both raises diagnostic accuracy and sensitivity; however, they cannot reliably distinguish benign from malignant disease
[6,8,11]. A size of greater than 3cm on ultrasonography should raise a
suspicion of PC [15]. Fine needle aspiration cytology should be avoided
in lesions that are suspected to be PC as it increases the risk of needle
tract dissemination, parathyromatosis, and recurrence [6]. Hence the
post-operative diagnosis of parathyroid carcinoma on histopathological
examination appears to be a norm rather than the exception [6].
The gold standard for the treatment of parathyroid carcinoma is
complete surgical excision of the tumor achieving microscopically negative margins. There is a limited role of chemotherapeutic agents and
radiotherapy in uncomplicated cases [6,7,9,16]. There is a lack of
evidence on prophylactic neck dissection. The incidence of neck metastasis has been reported to be 1–6% [6].
There is a high rate of locoregional recurrence rate ranging from 40
to 60% with nearly half of patients developing distant metastasis
[7,17]. Recurrence of the tumor is common within 2–3 years of initial
surgery. A close follow up and tumor surveillance is required. Serial
neck ultrasonography, serum calcium, phosphate, and parathyroid levels are required [6] 5- year disease-free survival rate after complete

Fig. 1. A 3.6 × 2.8cm complex solid and cystic nodule is seen on left side close
to left lower margin of thyroid measuring.

underwent neck ultrasonography which showed a complex solid and a
cystic nodule on the left side close to the lower pole of the thyroid
measuring 3.6 × 2.8 cm (Fig. 1).
The clinical picture was suggestive of a parathyroid adenoma and
she was admitted electively for its resection. After relevant investigations and anesthesia ﬁtness, she underwent complete excision of the left
parathyroid lesion and left lobectomy of thyroid gland under general
anesthesia. Intra-operative ﬁndings were enlarged left parathyroid
gland which was inseparable from the multi-nodular left lobe of the
thyroid gland. A recurrent laryngeal nerve was identiﬁed and saved.
Neck drain was placed and the sample was sent for histopathology
(Fig. 2). The lesion was not involving any other structure other than the
thyroid gland. No level VI lymphadenopathy was observed intraoperatively.
The patient remained hemodynamically stable with no signs of recurrent laryngeal nerve palsy. Her post-op serial serum calcium monitoring was done which decreased to normal range and remained

Fig. 2. Parathyroid carcinoma along with thyroid lobe after resection.
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Fig. 3. [A] Low power view of the neoplastic lesion
exhibiting ﬁbrous capsule (longer arrow), sheets of
cells and cystic spaces (shorter arrow) [B] The
neoplastic cells have pale to eosinopilic cytoplasm
and vesicular nuclei with inconspicuous nucleoli
[C] Few cells showed marked nuclear pleomorphism (arrows) [D] Focal invasion of parathyroid capsule (longer arrow) and extension into
thyroid tissue is also seen (shorter arrow).
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The case of parathyroid carcinoma described here presents two
unique features. Parathyroid cancer may present as a parathyroid
adenoma and hence complete surgical excision of suspicious malignant
lesion intra-operatively and close follow up post-operatively can provide an excellent long term disease free survival rate in patient without
adjuvant chemotherapy or radiotherapy. Secondly, complications associated with hyperparathyroidism may be absent in parathyroid carcinoma. Therefore clinicians should have a high index of suspicion for
parathyroid malignant lesions if the imaging shows unusual characteristics. Thyroid lobectomy should be performed to enhance the
clearance of malignant disease whenever deemed necessary.
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